Robert Farrell

Mr. Farrell has more than 30 years of experience in the pharmaceutical, biotechnology, and medical device sectors. Mr. Farrell has had primary or significant responsibility for the completion of mergers & acquisitions, corporate partnerships, licensing transactions, and divestitures in both the U.S. and Europe. In addition, Mr. Farrell has many years of operational experience, including responsibility for all financial operations.

Prior to joining Claritas Pharmaceuticals (formerly known as Kalytera) in 2016, Mr. Farrell worked as an executive officer with the Institute for One World Health, an affiliate of the Bill and Melinda Gates Foundation. Mr. Farrell has also held senior positions with publicly listed companies, including Titan Pharmaceuticals, where he served as President and CEO from 2008 to 2009 and as Chief Financial Officer from 1996 to 2008. Previously, Mr. Farrell served as Chief Financial Officer, Corporate Group Vice President, and General Counsel at Fresenius USA and Fresenius Medical Care. Mr. Farrell received a law degree (J.D.) from the University of California, and his undergraduate degree (B.A.) from the University of Notre Dame. Mr. Farrell is a member of the California State Bar.